Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10011452HBVENSG00000117601.15protein_codingSERPINC1NoNo462P01008
TVIS10011453HBVENSG00000117601.15protein_codingSERPINC1NoNo462P01008
TVIS10021160HBVENSG00000117601.15protein_codingSERPINC1NoNo462P01008
TCGA Plot Options
Drug Information
GeneSERPINC1
DrugBank IDDB06822
Drug NameTinzaparin
Target IDBE0000280
UniProt IDP01008
Regulation Typepotentiator
PubMed IDs19888521; 15767980; 15567452
CitationsBisio A, Vecchietti D, Citterio L, Guerrini M, Raman R, Bertini S, Eisele G, Naggi A, Sasisekharan R, Torri G: Structural features of low-molecular-weight heparins affecting their affinity to antithrombin. Thromb Haemost. 2009 Nov;102(5):865-73. doi: 10.1160/TH09-02-0081.@@Florian-Kujawski M, Hoppensteadt D, Maddineni J, Ziegler H, Fareed J: Differential regulation of thrombin activatable fibrinolytic inhibitor by low molecular weight heparins. Pharmacologic implications. Int Angiol. 2004 Dec;23(4):346-54.@@Morris TA, Jacobson A, Marsh JJ, Lane JR: Pharmacokinetics of UH and LMWH are similar with respect to antithrombin activity. Thromb Res. 2005;115(1-2):45-51.
GroupsApproved
Direct Classification
SMILES
Pathways
PharmGKB
ChEMBL